Iranian Journal of Cancer Prevention
Overview
Iranian Journal of Cancer Prevention is a scientific journal, published since 2008 in English. The journal's country of origin is Iran and its primary focus area is oncology.
Details
Recent Articles
1.
Abolghasemi H, Shahverdi E, Jafari R, Dolatimehr F, Khandani A
Iran J Cancer Prev
. 2016 Nov;
9(4):e5810.
PMID: 27822344
Introduction: Patients with immunosuppression have an increased incidence of toxoplasmosis characterized by involvement of the central nervous system. Only a few cases of toxoplasmosis associated with immunosuppressive agents have been...
2.
Anvari K, Toussi M, Shahidsales S, Motlagh F, Reza Ehsaee M, Afshari F
Iran J Cancer Prev
. 2016 Nov;
9(4):e4099.
PMID: 27822343
Background: Astrocytomas are the most common primary adult brain tumors. Objectives: In this study, we investigated the impact of some potential prognostic factors on survival in patients with low and...
3.
Dabiri R, Mahmoudi T, Farahani H, Nobakht H, Zali M
Iran J Cancer Prev
. 2016 Oct;
9(4):e8098.
PMID: 27761213
Background: With regard to the effect of calcium against colorectal cancer (CRC) and considering the key role of calcium sensing receptor (CaSR) in calcium homeostasis, this study investigated whether gene...
4.
Tabarestani S, Motallebi M, Akbari M
Iran J Cancer Prev
. 2016 Oct;
9(4):e6565.
PMID: 27761212
Context: Breast cancer is the most common cancer in women worldwide. Estrogen receptor (ER) positive breast cancer constitutes the majority of these cancers. Hormone therapy has significantly improved clinical outcomes...
5.
Hajian S, Mehrabi E, Simbar M, Houshyari M, Zayeri F, Hajian P
Iran J Cancer Prev
. 2016 Oct;
9(4):e5461.
PMID: 27761211
Background: Cancer diagnosis for everybody may be perceived as crisis and breast cancer, as the most common malignancy in women, can influence their well-being and multiple aspects of their health....
6.
Allahyari A, Hashemi S, Nazemian F, Karimi M, Kazemi M, Sadeghi M
Iran J Cancer Prev
. 2016 Oct;
9(4):e5045.
PMID: 27761210
Background: Acute lymphoblastic leukemia (ALL) is aggressive cancer, especially in adults as only 20-40% is cured with current treatment regimens. Objectives: The aim of this study is to evaluate prognostic...
7.
Akbari M, Atarbashi Moghadam S, Atarbashi Moghadam F, Bastani Z
Iran J Cancer Prev
. 2016 Oct;
9(4):e4467.
PMID: 27761209
Background: The incidence of oral cancers varies from one country to another, which can be clarified by the difference in the distribution of the risk factors and the possible etiologies....
8.
Rastgoosalami M, Memar B, Aledavood S, Fanipakdel A
Iran J Cancer Prev
. 2016 Oct;
9(4):e4404.
PMID: 27761208
Background: Aberrant expression of cancer-testis antigens (CTA) in breast carcinoma tissue, and its natural expression in the testis, the tissue away from the immune system, makes them good candidates for...
9.
Fathi A, Amani F, Davoodi M, Bahadoram S, Bahadoram M
Iran J Cancer Prev
. 2016 Oct;
9(4):e4277.
PMID: 27761207
Introduction: Nasopharyngeal carcinoma among the children has been rare accounting for only 1% of all pediatric malignancies. Both genetic and environmental factors have contributed to the development of nasopharyngeal carcinoma....
10.
Mohammadian F, Abhari A, Dariushnejad H, Nikanfar A, Pilehvar-Soltanahmadi Y, Zarghami N
Iran J Cancer Prev
. 2016 Oct;
9(4):e4190.
PMID: 27761206
Background: Recently, Chrysin, as a flavone, has revealed cancer chemo-preventive activity. The present experiment utilized the PLGA-PEG-chrysin complex, and free chrysin, to evaluation of the expression of miR-22, miR-34a and...